Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the study record page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Taoyuan, Taiwan, 333 to the study locations and removed Taoyuan District, Taiwan, 333 from the list, updating the Taiwan sites to reflect a city-level entry.SummaryDifference0.0%

- Check24 days agoChange DetectedThis update reflects a background change to the ClinicalTrials.gov page revision/version number, with no visible change to the study’s substantive content.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded location entries for Valparaiso, Araucania, Moravian-Silesian Region, and State of Vienna, and updated specific city entries to include the corresponding region names and postal codes (e.g., Vienna, State of Vienna, Austria, 1090; Temuco, Araucania, Chile, 4800827; Viña del Mar, Valparaiso, Chile; Ostrava, Moravian-Silesian Region, Czechia, 708 52). These changes replace prior region names (Vienna; Región de la Araucanía; Región de Valparaíso; Moravskoslezský kraj) with the updated regional qualifiers and reflect a revision from v3.5.0 to v3.5.2.SummaryDifference0.5%

- Check60 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131. The revision indicator changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.